The S&P Pharma Guy, Arthur Wong details four things S&P is watching for on Teva over the next three quarters that would help determine whether the ratings stay investment grade.
12/07/17 • 18 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/s-and-p-pharma-dose-101886/episode-25-four-things-we-are-watching-for-on-teva-5355202"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to episode 25: four things we are watching for on teva on goodpods" style="width: 225px" /> </a>
Copy